Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can an AI chatbot teach women to spot breast cancer risks?

NCT ID NCT07749677

Prevention Sponsor: Eskisehir Osmangazi University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial tests whether an AI chatbot can teach breast cancer awareness as effectively as expert-designed education. Female municipal employees are randomly assigned to receive AI-generated material, expert material, or no education. Their awareness is measured before, right after, and two months later. The goal is to see if AI can be a useful tool for spreading vital health information.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Artificial intelligence chatbot-generated educational material
What this could lead to
If effective, AI chatbots could provide a scalable, low-cost way to boost breast cancer awareness and screening behaviors in large populations.
What could go wrong
This is a small, single-site trial, and the chatbot content is static, not interactive. Results may not generalize, and awareness gains may not translate into actual screening uptake.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

150 people

The number who actually took part.

Started

Mar 2026

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female employees actively working within Eskişehir Odunpazarı Municipality * Aged 18 years or older * Literate * Having a smartphone to access the digital educational material * Agreeing to participate in the study Exclusion Criteria: * Previous diagnosis of or treatment for breast cancer * Not having a smartphone * Being a healthcare professional * Not completing the study process

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer awareness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Breast Self-Examination Health Education

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer awareness

Contacts and locations

Locations

  • Eskişehir Odunpazarı Municipality

    Odunpazari, Eskişehir, 26060, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.